JAMA Medical News
by JAMA Network
Is this your podcast?On the show
Recent episodes
What's Next for Lp(a)?
Oct 16, 2026
6m 02s
The Black Market for Investigational GLP-1 Drugs
Oct 9, 2026
5m 59s
What Happens When Children Use AI for Support?
Oct 2, 2026
5m 14s
Ovarian Cancer Is a Misnomer
Sep 25, 2026
5m 43s
The Challenge of Diagnosing Adult ADHD
Sep 18, 2026
5m 32s
Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Total monthly reach
Based on 1 signal.
Built from
By chart position
- 🇺🇸United States · MedicineHOME#4963K to 331K
- 🇯🇵Japan · Medicine#1112K to 66K
- 🇨🇦Canada · Medicine#601.9K to 10K
- 🇻🇳VN · Medicine#161.8K to 9.4K
- 🇰🇷South Korea · Medicine#461.4K to 7.2K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
86K to 456K🎙 ~2x weekly·301 episodes·Last published 3d ago - Monthly Reach
Unique listeners across all episodes (30 days)
172K to 912K🇺🇸73%🇯🇵14%🇨🇦2%+7 more - Active Followers
Loyal subscribers who consistently listen
95K to 501K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Description | Length | ||||||
|---|---|---|---|---|---|---|---|---|---|
| 10/16/26 |  What's Next for Lp(a)? | JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "Lp(a)-Reducing Agent Pelacarsen Misses the Mark in Phase 3—Now What?" Related Content: Lp(a)-Reducing Agent Pelacarsen Misses the Mark in Phase 3—Now What? | 6m 02s | ||||||
| 10/9/26 |  The Black Market for Investigational GLP-1 Drugs | JAMA Medical News Associate Managing Editor Kate Schweitzer and Lead Senior Staff Writer Rita Rubin discuss "Unapproved GLP-1 Drugs Retatrutide and Zenagamtide Sold Online Are No Bargain." Related Content: Unapproved GLP-1 Drugs Retatrutide and Zenagamtide Sold Online Are No Bargain | 5m 59s | ||||||
| 10/2/26 |  What Happens When Children Use AI for Support? | JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss 1 in 5 Children Report Using AI for Emotional Support--Is It Good News or Bad? Related Content: More Than 1 in 5 Children Report Using AI for Emotional Support—Is It Good News or Bad? | 5m 14s | ||||||
| 9/25/26 |  Ovarian Cancer Is a Misnomer | JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "Remove the Fallopian Tubes If the Opportunity Arises, ACOG Says in New Ovarian Cancer Prevention Guidance." Related Content: Remove the Fallopian Tubes If the Opportunity Arises, ACOG Says in New Ovarian Cancer Prevention Guidance | 5m 43s | ||||||
| 9/18/26 |  The Challenge of Diagnosing Adult ADHD | JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "As More Adults Seek ADHD Care, Primary Care Clinicians Are Tasked With Getting the Diagnosis Right." Related Content: As More Adults Seek ADHD Care, Primary Care Clinicians Are Tasked With Getting the Diagnosis Right | 5m 32s | ||||||
| 9/11/26 |  Researchers Turn to Viruses to Treat UTIs | JAMA Medical News Director Jennifer Abbasi and Staff Writer Samantha Anderer discuss "Is Phage Therapy the Next Big Hope for Urinary Tract Infections?" Related Content: Is Phage Therapy the Next Big Hope for Urinary Tract Infections? | 5m 38s | ||||||
| 9/11/26 |  A New Definition of MI and Other Heart Health Highlights From ESC Congress 2026 | Hear about a new universal definition of myocardial infarction, updated heart failure guidelines, and other clinical highlights in this interview with Tomasz Guzik, MD, PhD, chair of this year's European Society of Cardiology Congress. Related Content: A New Universal Definition of MI, Blood Pressure and Dementia, and More News From ESC Congress 2026 | 25m 05s | ||||||
| 9/9/26 |  The Fascinating Road to a New Narcolepsy Treatment | The winners of the 2026 Albert Lasker Basic Medical Research Award, Emmanuel Mignot, MD, PhD, and Masashi Yanagisawa, MD, PhD, discuss how they identified the neuropeptide orexin and deduced its role in narcolepsy. Related Content: How the Albert Lasker Winners Identified Orexin and Elucidated the Peptide's Role in Narcolepsy | 38m 39s | ||||||
| 9/4/26 |  What the Latest Research Says About Preventing Dementia | JAMA Medical News Director Jennifer Abbasi and Lead Senior Staff Writer Rita Rubin discuss "Nearly Half of Dementia Cases May Be Preventable—Here's What the Research Says So Far." Related Content: Nearly Half of Dementia Cases May Be Preventable—Here's What the Research Says So Far | 5m 38s | ||||||
| 8/28/26 |  Considering Cognition and Frailty in Cardiovascular Care—Too Big an Ask? | JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "Cardiovascular Care Should Incorporate Cognition and Frailty, Heart Group Says in New Statement." Related Content: Cardiovascular Care Should Incorporate Cognition and Frailty, Heart Group Says in New Statement | 5m 06s | ||||||
Want analysis for the episodes below?Free for Pro Submit a request, we'll have your selected episodes analyzed within an hour. Free, at no cost to you, for Pro users. | |||||||||
| 8/21/26 |  The Tip of the Iceberg Lettuce | JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "What the Cyclospora Outbreak Reveals About the State of US Foodborne Disease Surveillance." Related Content: What the Cyclospora Outbreak Reveals About the State of US Foodborne Disease Surveillance | 5m 29s | ||||||
| 8/14/26 |  FDA Approves the First mRNA Flu Vaccine for the US | JAMA Medical News Director Jennifer Abbasi and Lead Senior Staff Writer Rita Rubin discuss "What to Know About the mRNA Flu Vaccine, Newly Approved by the FDA." Related Content: What to Know About the mRNA Flu Vaccine, Newly Approved by the FDA | 5m 43s | ||||||
| 8/7/26 |  The Slow Evolution of Lyme Disease Care | JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "Will New Lyme Disease Approaches Change Patient Care?" Related Content: Will New Lyme Disease Approaches Change Patient Care? | 5m 25s | ||||||
| 7/31/26 |  Striking the Balance for Prescribing Opioids | JAMA Medical News Associate Managing Editor Kate Schweitzer and Staff Writer Samantha Anderer discuss "A Decade After the CDC's Opioid Prescribing Guidelines, Have Clinicians Struck the Right Balance?" Related Content: A Decade After the CDC's Opioid Prescribing Guidelines, Have Clinicians Struck the Right Balance? | 5m 22s | ||||||
| 7/31/26 |  Highlights From the 2026 Alzheimer's Association International Conference | Hear the latest on blood-based biomarkers, lifestyle interventions, and more from AAIC 2026 with Gil Rabinovici, MD. Related Content: Soccer Players' Brains, P-Tau217 Blood Tests, Lifestyle and Dementia Risk, and More From AAIC 2026 | 30m 59s | ||||||
| 7/24/26 |  The Menopause Treatment Boom | JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "Wild West or Gold Rush: How Long-Neglected Menopause Care Has Spawned a Booming Marketplace." Related Content: Wild West or Gold Rush: How Long-Neglected Menopause Care Has Spawned a Booming Marketplace | 5m 26s | ||||||
| 7/17/26 |  The First CKM Syndrome Guidelines Are Here | JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "What to Know About the First CKM Syndrome Guidelines." Related Content: What to Know About the First CKM Syndrome Guidelines | 5m 10s | ||||||
| 7/10/26 |  The Testosterone Therapy Debate | JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "Testosterone Therapy: Does New Evidence Warrant Broader Prescribing?" Related Content: Testosterone Therapy: Does New Evidence Warrant Broader Prescribing? | 5m 32s | ||||||
| 7/2/26 |  Alzheimer Disease Blood Test May Have Higher Rate of False Positives Than Expected | JAMA Medical News Associate Managing Editor Kate Schweitzer and Lead Senior Staff Writer Rita Rubin discuss "First Alzheimer Disease Blood Test May Produce Many False-Positive Results, Study Finds." Related Content: First Alzheimer Disease Blood Test May Produce Many False-Positive Results, Study Finds | 5m 32s | ||||||
| 6/26/26 |  PMOS is the New PCOS | JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "PCOS is Now PMOS—Will a New Name Translate to Improved Clinical Care?" Related Content: PCOS Is Now PMOS—Will a New Name Translate to Improved Clinical Care? | 5m 35s | ||||||
| 6/18/26 |  Why Exercise Still Matters in the GLP-1 Drug Era | JAMA Medical News Director Jennifer Abbasi and Staff Writer Samantha Anderer discuss "In Obesity Treatment, Physical Activity's Benefits Go Beyond Weight Loss, Says AHA." Related Content: In Obesity Treatment, Physical Activity's Benefits Go Beyond Weight Loss, Says AHA | 4m 57s | ||||||
| 6/18/26 |  New GLP-1 Drug Options and More Highlights From the ADA's 2026 Scientific Sessions | Rita Kalyani, MD, chief scientific and medical officer at the American Diabetes Association, discusses the latest diabetes and obesity research, including a novel oral GLP-1 drug, a combined semaglutide-amylin analogue injection, data from China on high-dose mazdutide, and more. Related Content: A New GLP-1 Pill for Diabetes, Semaglutide With Amylin, Data From China, and More From ADA 2026 | 22m 49s | ||||||
| 6/12/26 |  The Search for a Fentanyl Vaccine | JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "Inside the Push for a Fentanyl Vaccine." Related Content: Inside the Push for a Fentanyl Vaccine | 5m 32s | ||||||
| 6/5/26 |  New Insights on HFpEF in Patients With Severe Obesity | JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "HFpEF May Be a Different Disease in Patients With Severe Obesity." Related Content: HFpEF May Be a Different Disease in Patients With Severe Obesity | 4m 48s | ||||||
| 5/29/26 |  Is There a Doctor on the Ship? | Joining from quarantine, Stephen Kornfeld, MD, discusses his experience stepping in as the ship's physician when hantavirus transformed his vacation cruise into a global public health concern. Related Content: Hantavirus Outbreak: First Test of US Public Health Response After WHO Withdrawal When Hantavirus Sickened the Ship's Physician, Stephen Kornfeld, MD, Stepped Up | 17m 03s | ||||||
Showing 25 of 301
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.
Similar Audience Demographics
Podcasts that attract a similar listener profile
Chart history for JAMA Medical News
Peaked at #11 in Japan, currently #11 in Japan.
| Market | Genre | Peak | Current | Trend |
|---|---|---|---|---|
| Japan | — | #11 | #11 | — |
| VN | — | #16 | #16 | — |
| CL | — | #31 | #31 | — |
| HK | — | #39 | #39 | — |
| TR | — | #43 | #43 | — |
| South Korea | — | #46 | #46 | — |
| SG | — | #46 | #46 | — |
| United States | — | #49 | #49 | — |
| Canada | — | #60 | #60 | — |
| NG | — | #61 | #61 | — |
| Australia | — | #69 | #69 | — |
| PE | — | #75 | #75 | — |
| IL | — | #83 | #83 | — |
| AR | — | #95 | #95 | — |
| Mexico | — | #104 | #104 | — |
| Japan | — | #116 | #116 | — |
| TH | — | #116 | #116 | — |
| TW | — | #117 | #117 | — |
| South Africa | — | #119 | #119 | — |
| Norway | — | #125 | #125 | — |
Chart Positions
33 placements across 32 markets.
Chart Positions
33 placements across 32 markets.